Programme November 28, 2022

    VERDANA  -  Monday 28/11/2022  

 8:45 - 9:00  Opening Ceremony Chairpersons: A. Linhart, M. Táborský, P. Ošťádal (Praha, Olomouc)
 9:00 - 10:30  Congenital & Valvular Diseases Chairpersons: T. Paleček, V. Chaloupecký (Praha)
 9:001. 21 YEARS FOLLOW-UP OF LIVER FUNCTION IN PATIENTS AFTER FONTAN OPERATION D. Jičínská, O. Materna, P. Antonová, K. Koubský, M. Jičínský, M. Štefánek, J. Janoušek, V. Chaloupecký (Praha) (UID: 2)
 9:152. ROSS PROCEDURE PROVIDES SURVIVAL BENEFIT OVER MECHANICAL VALVE IN ADULTS: A PROPENSITY-MATCHED NATIONWIDE ANALYSIS J. Gofus, P. Fila, S. Drabkova, P. Žáček, J. Ondrášek, P. Němec, M. Tuna, J. Jarkovsky, J. Vojáček (Hradec Králové, Brno, Prague) (UID: 6)
 9:303. RETROSPECTIVE COMPARISON OF AORTIC VALVE ANNULUS EVALUATION IN PATIENTS WITH SEVERE AORTIC STENOSIS IN PATIENTS PLANNED FOR TAVI PROCEDURE P. Kmoníček, M. Mates, K. Kopřiva, T. Mráz , F. Holý (Praha) (UID: 40)
 9:454. COMBINED STRATEGY FOR LARGE-BORE ARTERIOTOMY CLOSURE AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION M. Sluka, R. Nykl, J. Ostřanský (Olomouc) (UID: 80)
 10:005. PARAMETERS OF ALLERGIC REACTION AFTER IMPLANTATION OF DIFFERENT PATENT FORAMEN OVALE OCCLUDERS - A PILOT PROSPECTIVE RANDOMIZED STUDY A. Dvořáková, M. Mates, P. Kmoníček, K. Kopřiva, P. Neužil (Praha) (UID: 17)
 10:156. ECHOCARDIOGRAPHY IS INFERIOR TO COMPUTED TOMOGRAPHY IN PREDICTING BALLOON EXPANDABLE TRANSCUTANEOUS IMPLANTATION VALVE SIZE IN ROUTINE CLINICAL SETTING-SINGLE CENTRE STUDY K. Mědílek, J. Bis, P. Polanský, J. Dušek, M. Brtko, T. Kvasnička, M. Tuna, R. Praus, M. Ballon, J. Šťásek (Hradec Králové, Pardubice) (UID: 125)
 10:30  Break  
 11:00 - 12:30  Myocardial Ischemia & Coronary Syndromes I Chairpersons: P. Ošťádal, V. Jakovljevic (Praha, Kragujevac, Serbia)
 11:007. ANTIPLATELET AGENTS AS A NOVEL THERAPY OF HEART FAILURE DUE TO MYOCARDIOAL INFRACTION N. Dhalla (Manitoba, Canada) (UID: 84)
 11:158. EXCESS ISCHEMIC TACHYARRHYTHMIAS TRIGGER PROTECTION AGAINST MYOCARDIAL INFARCTION IN HYPERTENSIVE RATS. J. Neckář, P. Alánová, V. Olejníčková, F. Papoušek, J. Hrdlička, L. Hejnová, M. Behuliak, J. Šilhavý, M. Štengl, F. Kolář (Praha, Plzeň) (UID: 13)
 11:309. PERFLUOROCARBON BASED BLOOD SUBSTITUTE PERFTORAN IN ANIMAL MODEL OF ISCHEMIA - REPERFUSION INJURY V. Jakovljevic (Kragujevac, Serbia) (UID: 85)
 11:4510. CARDIAC TOLERANCE TO ISCHEMIA: DEVELOPMENTAL AND SEX DIFFERENCES B. Ošťádal, F. Kolář, D. Sedmera, I. Ošťádalová, M. Hlaváčková, V. Olejníčková, P. Alánová (Praha, Prague) (UID: 8)
 12:0011. FUNCTIONAL ASSESSMENT OF MICROCIRCULATION IN TAKOTSUBO CARDIOMYOPATHY – A PILOT STUDY V. Brázdil, M. Hudec, O. Boček, P. Jeřábek, J. Kaňovský, M. Poloczek, R. Štípal, P. Kala (Brno) (UID: 55)
 12:15  Diskuze  
 12:30  Lunch  
 13:30 - 15:30  Heart Failure Chairpersons: F. Málek, Z. Papp (Praha, Debrecen, Hungary)
 13:3012. CARDIAC MYOFILAMENTS AS TARGETS IN THE MANAGEMENT OF HEART FAILURE Z. Papp (Debrecen, Hungary) (UID: 87)
 13:4513. ACUTE SEVERE HEART FAILURE IMMEDIATELY REDUCES HEART RATE VARIABILITY: AN EXPERIMENTAL STUDY IN PORCINE MODEL. J. Naar, M. Mlček, A. Krüger, D. Vondráková, M. Janotka, M. Popková, O. Kittnar, P. Neužil, P. Ošťádal (Prague, Praha, Praha 5) (UID: 9)
 14:0014. SGC STIMULATOR (BAY 41-8543) FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AND CARDIO-RENAL SYNDROME O. Gawrys, Z. Husková, P. Škaroupková, Z. Honetschlägerová, Z. Vaňourková , S. Kikerlová , V. Melenovský , L. Červenka (Praha) (UID: 10)
 14:1515. LONG-TERM CLINICAL OUTCOMES AND LEFT VENTRICULAR REVERSE REMODELING IN PATIENTS WITH RECENTLY DIAGNOSED UNEXPLAINED DILATED CARDIOMYOPATHY P. Kuchynka, J. Podzimkova, J. Marek, B. Danek, I. Vitkova, M. Kreidlova, L. Roblova, T. Kovarnik, A. Linhart, T. Paleček (Praha, Seattle, United States) (UID: 24)
 14:3016. LV SIZE NEEDS TO BE INCORPORATED IN LV FUNCTION ASSESSMENT IN HFREF PATIENTS K. Kroupová, P. Wohlfahrt, M. Kotrč, V. Melenovský, J. Kautzner, J. Beneš (Praha) (UID: 47)
 14:4517. METFORMIN TREATMENT IS ASSOCIATED WITH IMPROVED QUALITY OF LIFE AND OUTCOME IN PATIENTS WITH DIABETES AND ADVANCED HEART FAILURE (HFREF) J. Beneš, M. Kotrč, K. Kroupová, P. Wohlfahrt, J. Kovář, J. Franeková, L. Hošková, T. Pelikánová, J. Kautzner, V. Melenovský (Praha) (UID: 46)
 15:0018. STRESS PULMONARY CIRCULATION PARAMETERS IN PATIENTS AFTER A HEART TRANSPLANT AND CANCER SURVIVORS: A CARDIOVASCULAR MAGNETIC RESONANCE STUDY L. Opatřil, R. Panovský, M. Mojica-Pisciotti, J. Máchal, J. Krejčí, T. Holeček, V. Feitová, V. Kincl, T. Kepák, L. Špinarová (Brno) (UID: 49)
 15:1519. CHARACTERISTICS AND OUTCOMES OF PATIENTS ADMITTED FOR ACUTE HEART FAILURE IN A SINGLE CENTRE STUDY J. Dokoupil, J. Hrečko, E. Čermáková, M. Adamcová, R. Pudil (Hradec Králové) (UID: 3)
 15:30  Break  
 16:00 - 17:30  Stroke Chairpersons: P. Widimský, P. Kala (Praha, Brno)
 16:0020. THE ROLE OF THE CARDIOLOGIST ON THE STROKE UNIT W. Doehner (Berlin, Germany) (UID: 89)
 16:1521. CATHETER THROMBECTOMY FOR ACUTE ISCHEMIC STROKE IN CARDIOLOGY CATH LAB: 10 YEARS RESULTS J. Křeček, D. Kučera, B. Kožnar, J. Sulženko, P. Widimský, I. Štětkářová, T. Peisker, P. Vaško (Praha) (UID: 16)
 16:3022. TRANSOESOPHAGEAL ECHOCARDIOGRAPHY FINDINGS IN YOUNG PATIENTS WITH CRYPTOGENIC ISCHEMIC STROKE M. Hutyra, D. Šaňák , M. Král, J. Přeček, E. Čecháková, M. Köcher, T. Veverka, Z. Tüdös, M. Táborský (Olomouc) (UID: 70)
 16:4523. TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) IS ASSOCIATED WITH CARDIAC INJURY AND STROKE SEVERITY IN PATIENTS AFTER ACUTE ISCHEMIC STROKE M. Mihalovič, P. Mikulenka, H. Línková, D. Lauer, I. Štětkářová, P. Toušek (Praha) (UID: 57)
 17:0024. PREDICTING LONG-TERM SURVIVAL AFTER AN ISCHEMIC STROKE R. Cífková, P. Wohlfahrt, A. Krajčoviechová, O. Mayer Jr, J. Vaněk, D. Hlinovský, L. Kielbergerová, V. Lánská (Prague, Plzeň, Praha) (UID: 64)
 17:15  Diskuze  
 17:30  End of program  


    TAHOMA  -  Monday 28/11/2022  

 9:00 - 10:30  Myocardial Diseases I Chairpersons: A. Linhart, J. Krejčí (Praha, Brno)
 9:0025. NATION-WIDE SCREENING OF FABRY DISEASE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY IN CZECH REPUBLIC (BY DRY BLOOD SPOT METHOD) D. Zemánek, J. Januška, T. Honěk, K. Čurila, M. Kubánek, Š. Šindelářová, L. Zahálková, P. Klofáč, G. Dostálová, A. Linhart (Praha, Třinec, Brno, České Budějovice, Hradec Králová, Liberec) (UID: 27)
 9:1226. HEART FAILURE IN FABRY DISEASE REVISITED: APPLICATION OF CURRENT HEART FAILURE GUIDELINES AND RECOMMENDATIONS D. Rob, J. Marek, G. Dostálová, A. Linhart (Praha) (UID: 54)
 9:2427. DIURETIC USE IN HEART FAILURE W. Mullens (Genk, Belgium) (UID: 91)
 9:3628. ROLE OF MYOCARDIAL DEFORMATION ANALYZED BY 3D ECHOCARDIOGRAPHY IN FABRY DISEASE J. Marek, D. Rob, G. Dostálová, P. Kuchynka, Z. Hlubocká, B. Chocholová, A. Linhart (Praha) (UID: 65)
 9:4829. MYOCARDIAL INVOLVEMENT DETECTED USING CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS WITH SYSTEMIC SCLEROSIS – A PROSPECTIVE OBSERVATIONAL STUDY M. Hromádka, J. Baxa, D. Rajdl, R. Rokyta (Plzeň) (UID: 12)
 10:0030. DUCHENNE MUSCULAR DYSTROPHY: CARDIAC PHENOTYPE AS A RESULT OF DNA DAMAGE-INDUCED CHANGE OF STEM CELL FATE. V. Rotrekl, M. Pešl, D. Beckerová, Š. Jelínková, A. Lacampagne, A. Meli (Brno, Montpellier, France) (UID: 78)
 10:1231. SPECIFIC TREATMENT OF CARDIOMYOPATHIES A. Linhart (Praha) (UID: 92)
 10:30  Break  
 11:00 - 12:30  Arrhytmia & Electrophysiology I Chairpersons: M. Táborský, J. Kautzner (Olomouc, Praha)
 11:0032. NITRIC OXIDE RELEASING PACING LEAD TO PREVENT INFECTION IN CARDIAC PACING P. Hála, O. Lautner-Csorba, R. Gorur, M. Popková, V. Somaya, D. Janák, M. Mlček, P. Neužil, O. Kittnar, T. Major (Praha, Ann Arbor, United States, Ann Arbor) (UID: 39)
 11:1533. LEFT BUNDLE BRANCH PACING OF PROXIMAL LEFT BUNDLE BRANCH AND SEPTAL FASCICLE PRODUCES MORE PHYSIOLOGICAL ACTIVATION COMPARED TO PACING OF THE ANTERIOR FASCICLE O. Süssenbek, P. Jurák, M. Jastrzebski, P. Štros, P. Waldauf, R. Smíšek, J. Halámek, L. Znojilová, P. Osmančík, K. Čurila (Praha 10, Brno, Krakow, Poland, Praha) (UID: 51)
 11:3034. BIMODAL DISTRIBUTION OF QRS COMPLEX DURATION IN PATIENTS WITH DILATED CARDIOMYOPATHY UNDERGOING AN ICD IMPLANT PROCEDURE. V. Vančura, V. Vejvoda, T. Jandík, J. Šmíd, M. Ulrychová, R. Rokyta (Plzeň) (UID: 62)
 11:4535. DETECTION OF ARRHYTHMIAS IN PATIENTS WITH CARDIAC AMYLOIDOSIS USING IMPLANTABLE ECG RECORDERS. M. Táborský (Ústí nad Labem) (UID: 31)
 12:0036. ABSENCE OF HEART RATE VARIABILITY CHANGE DURING FOLLOW UP AFTER COVID-19 DOESN’T SUGGEST DIRECT CARDIOVASCULAR IMPACT G. Matejová, M. Radvan, P. Kala, M. Kameník, L. Koc (Brno) (UID: 72)
 12:15  Diskuze  
 12:30  Lunch  
 13:30 - 15:30  Arrest & Shock Chairpersons: J. Bělohlávek, P. Ošťádal (Praha)
 13:3037. REGULATION OF CELL DEATH PATHWAYS IN THE HEART L. Kirshenbaum (Winnipeg, Canada) (UID: 129)
 13:4538. PRAGUE OHCA - SUBGROUP ANALYSES J. Bělohlávek (Praha) (UID: 97)
 14:0039. GENDER DIFFERENCES AND SURVIVAL AFTER OUT OF HOSPITAL CARDIAC ARREST D. Rob, P. Kaválková, J. Šmalcová, O. Franěk, A. Komárek, M. Pisinger, J. Bělohlávek (Praha, Ceske Budejovice) (UID: 53)
 14:1540. VENTRICULAR ARRHYTMIAS IN PATIENTS WITH IMPLANTED ICD: A POST HOC ANALYSIS OF PRAGUE OHCA TRIAL I. Šotolová, M. Válek, J. Šmalcová, D. Rob, Š. Havránek, J. Bělohlávek (Praha) (UID: 48)
 14:3041. LACTATE IN REFRACTORY OUT-OF-HOSPITAL CARDIAC ARREST. THE PRAGUE OHCA STUDY SUBANALYSIS. M. Dusík, J. Šmalcová, D. Rob, Š. Havránek, O. Šmíd, H. Lahoda Brodská, M. Huptych, J. Bělohlávek (Praha) (UID: 56)
 14:4542. COMPARISON OF NEURON-SPECIFIC ENOLASE, TAU-PROTEIN AND NEUROFILAMENT LIGHT CHAIN VALUES FOR EARLY PROGNOSTICATION IN CARDIAC ARREST SURVIVORS D. Vondráková, A. Krüger, M. Janotka, J. Naar, P. Neužil, O. Sobek, P. Ošťádal (Praha) (UID: 66)
 15:0043. EFFECT OF VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION ON LEFT VENTRICULAR FUNCTION IN CARDIOGENIC SHOCK WITH AORTIC STENOSIS OR MITRAL REGURGITATION: AN EXPERIMENTAL STUDY IN PORCINE MODEL P. Ošťádal, D. Vondráková, M. Popková, M. Hrachovina, A. Krüger, M. Janotka, J. Naar, O. Kittnar, P. Neužil, M. Mlček (Praha, Prague) (UID: 25)
 15:15  Diskuze  
 15:30  Break  
 16:00 - 17:30  Cardiovascular Prevention I Chairpersons: M. Vrablík, G. Pierce (Praha, Winnipeg, Canada)
 16:0044. THE PROGRESSION AND TRANSLATION OF A CARDIOVASCULAR RESEARCH PROJECT FROM BASIC SCIENCE TO CLINICAL TRIAL WITH A NUTRITIONAL EMPHASIS G. Pierce (Winnipeg, Canada) (UID: 96)
 16:1545. IN VITRO ASSESSMENT OF ANTI-INFLAMMATORY AND CYTOTOXICITY PROPERTIES OF COLCHICINE M. Malý, J. Viktorová, O. Strnad, T. Ruml, M. Stránská (Praha) (UID: 19)
 16:3046. HYPERTRIGLYCERIDEMIC GENE SCORE IN PATIENTS WITH APOE2/E2 GENOTYPE AS A POSSIBLE PREDICTOR OF FAMILIAL DYSBETALIPOPROTEINEMIA M. Šatný, T. Altschmiedová, V. Todorovová, M. Vrablík, O. Kyselák, V. Soška, J. Hubáček (Praha, Brno) (UID: 42)
 16:4547. FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN CZECH POPULATION AND IN CZECH PATIENTS WITH ACUTE CORONARY SYNDROME J. Hubáček, J. Piťha, V. Adámková (Prague, Praha) (UID: 38)
 17:00  Diskuze  
 17:30  End of program